160 related articles for article (PubMed ID: 15514090)
1. Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19.
D'Amour P; Brossard JH; Räkel A; Rousseau L; Albert C; Cantor T
Clin Chem; 2005 Jan; 51(1):169-76. PubMed ID: 15514090
[TBL] [Abstract][Full Text] [Related]
2. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism.
D'Amour P; Brossard JH; Rousseau L; Nguyen-Yamamoto L; Nassif E; Lazure C; Gauthier D; Lavigne JR; Zahradnik RJ
Kidney Int; 2005 Sep; 68(3):998-1007. PubMed ID: 16105030
[TBL] [Abstract][Full Text] [Related]
3. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism.
D'Amour P; Brossard JH; Rousseau L; Roy L; Gao P; Cantor T
Clin Chem; 2003 Dec; 49(12):2037-44. PubMed ID: 14633875
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
Gao P; D'Amour P
Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
[TBL] [Abstract][Full Text] [Related]
5. Immunochemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormone.
Gao P; Schmidt-Gayk H; Dittrich K; Nolting B; Maier A; Roth HJ; Seemann O; Reichel H; Ritz E; Schilling T
Clin Chim Acta; 1996 Feb; 245(1):39-59. PubMed ID: 8646814
[TBL] [Abstract][Full Text] [Related]
6. Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays.
Nguyen-Yamamoto L; Rousseau L; Brossard JH; Lepage R; Gao P; Cantor T; D'Amour P
Eur J Endocrinol; 2002 Jul; 147(1):123-31. PubMed ID: 12088929
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients.
Hackeng WH; Lips P; Netelenbos JC; Lips CJ
J Clin Endocrinol Metab; 1986 Aug; 63(2):447-53. PubMed ID: 3088025
[TBL] [Abstract][Full Text] [Related]
8. Immunoassays for the detection of parathyroid hormone.
Jüppner H; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
[TBL] [Abstract][Full Text] [Related]
9. Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands.
Flueck JA; Di Bella FP; Edis AJ; Kehrwald JM; Arnaud CD
J Clin Invest; 1977 Dec; 60(6):1367-75. PubMed ID: 915003
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications.
Brossard JH; Yamamoto LN; D'Amour P
Semin Dial; 2002; 15(3):196-201. PubMed ID: 12100458
[TBL] [Abstract][Full Text] [Related]
11. Immunological evidences for the presence of small late carboxylterminal fragment(s) of human parathyroid hormone (PTH) in circulation in man.
D'Amour P; Labelle F; Wolde-Giorghis R; Hamel L
J Immunoassay; 1989; 10(2-3):191-205. PubMed ID: 2745718
[TBL] [Abstract][Full Text] [Related]
12. Multisite immunochemiluminometric assay for simultaneously measuring whole-molecule and amino-terminal fragments of human parathyrin.
Klee GG; Preissner CM; Schryver PG; Taylor RL; Kao PC
Clin Chem; 1992 May; 38(5):628-35. PubMed ID: 1582012
[TBL] [Abstract][Full Text] [Related]
13. An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma.
Rubin MR; Silverberg SJ; D'Amour P; Brossard JH; Rousseau L; Sliney J; Cantor T; Bilezikian JP
Clin Chem; 2007 Aug; 53(8):1470-6. PubMed ID: 17599957
[TBL] [Abstract][Full Text] [Related]
14. Selective determination of C-terminal (70-84) hPTH: elevated concentrations in cholestatic liver disease.
Rittinghaus EF; Jüppner H; Burdelski M; Hesch RD
Acta Endocrinol (Copenh); 1986 Jan; 111(1):62-8. PubMed ID: 3946104
[TBL] [Abstract][Full Text] [Related]
15. Human parathyroid hormone. Immunological characterization of antibodies against a glandular extract and the synthetic amino-terminal fragments 1-12 and 1-34 and their use in the determination of immunoreactive hormone in human sera.
Fischer JA; Binswanger U; Dietrich FM
J Clin Invest; 1974 Dec; 54(6):1382-94. PubMed ID: 4474187
[TBL] [Abstract][Full Text] [Related]
16. Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor.
Nguyen-Yamamoto L; Rousseau L; Brossard JH; Lepage R; D'Amour P
Endocrinology; 2001 Apr; 142(4):1386-92. PubMed ID: 11250917
[TBL] [Abstract][Full Text] [Related]
17. Acute regulation of circulating parathyroid hormone (PTH) molecular forms by calcium: utility of PTH fragments/PTH(1-84) ratios derived from three generations of PTH assays.
D'Amour P; Räkel A; Brossard JH; Rousseau L; Albert C; Cantor T
J Clin Endocrinol Metab; 2006 Jan; 91(1):283-9. PubMed ID: 16219713
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function.
Gao P; Scheibel S; D'Amour P; John MR; Rao SD; Schmidt-Gayk H; Cantor TL
J Bone Miner Res; 2001 Apr; 16(4):605-14. PubMed ID: 11315988
[TBL] [Abstract][Full Text] [Related]
19. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples.
Lepage R; Roy L; Brossard JH; Rousseau L; Dorais C; Lazure C; D'Amour P
Clin Chem; 1998 Apr; 44(4):805-9. PubMed ID: 9554492
[TBL] [Abstract][Full Text] [Related]
20. Direct in vitro evidence of extracellular Ca2+-induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells.
Kawata T; Imanishi Y; Kobayashi K; Onoda N; Takemoto Y; Tahara H; Okuno S; Ishimura E; Miki T; Ishikawa T; Inaba M; Nishizawa Y
J Clin Endocrinol Metab; 2005 Oct; 90(10):5774-8. PubMed ID: 16046589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
